HUP1300504A2 - Sorafenib salts - Google Patents

Sorafenib salts

Info

Publication number
HUP1300504A2
HUP1300504A2 HU1300504A HUP1300504A HUP1300504A2 HU P1300504 A2 HUP1300504 A2 HU P1300504A2 HU 1300504 A HU1300504 A HU 1300504A HU P1300504 A HUP1300504 A HU P1300504A HU P1300504 A2 HUP1300504 A2 HU P1300504A2
Authority
HU
Hungary
Prior art keywords
sorafenib
salts
sorafenib salts
Prior art date
Application number
HU1300504A
Other languages
Hungarian (hu)
Inventor
Imre Kiraly
Janos Levente Heder
Tamas Gregor
Balazs Volk
Lauritz Maria Tothne
Laszlo Pongo
Katalin Buete
Gyula Lukacs
Zoltan Varga
Andras Dancso
Original Assignee
Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag filed Critical Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag
Priority to HU1300504A priority Critical patent/HUP1300504A2/en
Priority to PCT/HU2014/000074 priority patent/WO2015028828A1/en
Publication of HUP1300504A2 publication Critical patent/HUP1300504A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
HU1300504A 2013-08-27 2013-08-27 Sorafenib salts HUP1300504A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1300504A HUP1300504A2 (en) 2013-08-27 2013-08-27 Sorafenib salts
PCT/HU2014/000074 WO2015028828A1 (en) 2013-08-27 2014-08-26 Sorafenib salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1300504A HUP1300504A2 (en) 2013-08-27 2013-08-27 Sorafenib salts

Publications (1)

Publication Number Publication Date
HUP1300504A2 true HUP1300504A2 (en) 2015-03-30

Family

ID=89991236

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1300504A HUP1300504A2 (en) 2013-08-27 2013-08-27 Sorafenib salts

Country Status (2)

Country Link
HU (1) HUP1300504A2 (en)
WO (1) WO2015028828A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3038534A1 (en) * 2016-09-30 2018-04-05 Intercept Pharmaceuticals, Inc. Crystalline forms of a bile acid derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101584661B (en) * 2009-06-10 2011-06-08 北京大学 Preparation of sorafenib self-microemulsifying drug delivery system for oral administration or intravenous injection and use thereof
EP2480535A1 (en) * 2009-09-24 2012-08-01 Ranbaxy Laboratories Limited Polymorphs of sorafenib acid addition salts

Also Published As

Publication number Publication date
WO2015028828A1 (en) 2015-03-05

Similar Documents

Publication Publication Date Title
HK1215795A1 (en) Amatoxin derivatives
HK1226347A1 (en) Aramchol salts
GB2533229B (en) Mineral-encapsulated tracers
SG11201506100XA (en) Pyridazinone-amides derivatives
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
HK1213876A1 (en) Substituted imidazopyridazines
AP2016009025A0 (en) Substituted pyrazolo-pyridinamines
SG11201605189YA (en) Imidazopyrazinone derivatives
PL3068827T3 (en) Bitumenpolymerzusammensetzung mit verbesserten mechanischen kälteeigenschaften
HK1220972A1 (en) Substituted thiazolopyrimidines
AP2016009303A0 (en) Substituted piperidinyl-tetrahydroquinolines
HUP1300504A2 (en) Sorafenib salts
PL2846091T3 (en) Oxy-gas-brenner mit glühzündung
HUP1300332A2 (en) Lapatinib salts
GB201304374D0 (en) Full stop
IL245452A0 (en) Aramchol salt
GB2519519B (en) Stop
GB201311202D0 (en) Tracers

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal